Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Trump calls Biden’s cancer diagnosis ‘very sad’ while questioning timeline: ‘Wasn’t informed’

by admin May 20, 2025
May 20, 2025
Trump calls Biden’s cancer diagnosis ‘very sad’ while questioning timeline: ‘Wasn’t informed’

President Donald Trump spoke candidly about former President Joe Biden’s recent prostate cancer diagnosis on Monday, expressing sympathy while also suggesting that the situation should be investigated.

Biden’s team announced the diagnosis on Sunday afternoon, saying that the former statesman ‘was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms.’

‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone,’ the statement added.

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,’ Biden’s team concluded. ‘The President and his family are reviewing treatment options with his physicians.’

Speaking to reporters on Monday afternoon, Trump called the news ‘very sad, actually.’ 

‘I’m surprised that…you know, the public wasn’t notified a long time ago because to get to stage nine [sic], that’s a long time,’ Trump said. ‘I just had my physical… We had the doctors at the White House and over at Walter Reed, which is a fantastic hospital. I did a very complete physical, including cognitive tests.’

Trump also referenced Biden’s cognitive decline during his presidency, stating that ‘anybody running for president should take a cognitive test.’

‘They say it’s unconstitutional. But I would say in that particular case, having a cognitive test wouldn’t be so bad,’ the Republican said.

Trump also posited that the general public ‘wasn’t informed’ about Biden’s medical situation, and suggested that the situation should be investigated.

‘I think somebody is going to have to speak to his doctor if it’s the same, or even if it’s two separate doctors,’ Trump said. ‘Why wasn’t the cognitive ability, why wasn’t that discussed? And I think the doctor said he’s just fine. And it’s turned out that’s not so. It’s very dangerous.’

The president concluded by saying that the cancer diagnosis is ‘a very, very sad situation and I feel very badly about it.’

‘I think people should try and find out what happened, because I’ll tell you….I don’t know if it had anything to do with the hospital,’ Trump added. ‘Walter Reed is really good. There’s some of the best doctors I’ve ever seen.’

‘Somebody is not telling the facts,’ he concluded. ‘It’s a big problem.’

News of Biden’s aggressive cancer diagnosis shocked the country over the weekend. After receiving bipartisan messages of sympathy, the 82-year-old thanked his supporters on social media on Monday.

‘Cancer touches us all,’ Biden wrote on X. ‘Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support.’

This post appeared first on FOX NEWS

previous post
Schumer ripped for placing blame on Trump, DOGE for deadly Mexican Navy crash in NYC: ‘He is an idiot’
next post
Trump considers former defense attorney Emil Bove for federal appeals court vacancy

Related Posts

Far-left congresswoman revives ousted ‘Squad’ Dem’s reparations push...

May 16, 2025

Warren explains her applause to Trump’s ‘Pocahontas’ jab...

March 7, 2025

Disgraced lawyer Michael Avenatti seeks mercy at resentencing,...

May 8, 2025

India launches strikes on terrorist camps in Pakistan

May 7, 2025

Trump envoy Richard Grenell secures freedom for 6...

February 1, 2025

Former Trump officials reject whistleblower claim that FBI...

January 29, 2025

Hostages freed from Gaza tell Trump he was...

March 8, 2025

Trump promises to ramp up energy production, lower...

March 5, 2025

Moderates reveal why they didn’t join fellow Dems...

March 7, 2025

Vance visits Capitol Hill to urge senators to...

March 5, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved